AbbVie (ABBV) Tax Rate (2012 - 2026)

AbbVie (ABBV) reported Tax Rate of 32.92% for Q1 2026, up 1052.0% year-over-year from 2.86% in Q1 2025, and up 2.95% quarter-over-quarter from 31.97% in Q4 2025.

AbbVie (ABBV) Tax Rate (2012 - 2026) Analysis & Trends

AbbVie (ABBV) has 15 years of Tax Rate data on file, last reported at 32.92% in Q1 2026.

  • Tax Rate for Q1 2026 came in at 32.92%, up 1052.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 39.06% (up 5510.0% YoY), and the FY2025 annual result was 35.83%, up 5117.0% from the prior year.
  • Tax Rate advanced to 32.92% in Q1 2026 per ABBV's latest filing, from 31.97% in the prior quarter.
  • Over five years, Tax Rate peaked at 120.42% in Q1 2023 and troughed at 8.81% in Q3 2023.
  • A 5-year average of 36.65% and a median of 24.95% in 2024 frame the typical range for Tax Rate.
  • The sharpest annual moves came in 2023 and 2024: Tax Rate jumped 11158 bps in 2023, then sank 9860 bps in 2024.
  • A 5-year view of Tax Rate shows it stood at 16.63% in 2022, then soared by 93 bps to 32.01% in 2023, then soared by 209 bps to 98.99% in 2024, then tumbled by 68 bps to 31.97% in 2025, then climbed by 3 bps to 32.92% in 2026.
  • Business Quant data shows ABBV's Tax Rate at 32.92% in Q1 2026, 31.97% in Q4 2025, and 73.67% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn -14.23
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 16.43
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 12.60
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 32.92
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn -20.26
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 12.72
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 21.67
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 14.54
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 17.31
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 32.92%
Mar 31, 2026 32.92%
Dec 31, 2025 31.97%
Dec 31, 2025 31.97%
Sep 30, 2025 73.67%
Sep 30, 2025 73.67%
Jun 30, 2025 39.45%
Jun 30, 2025 39.45%
Mar 31, 2025 22.40%
Mar 31, 2025 22.40%
Dec 31, 2024 98.99%
Dec 31, 2024 98.99%
Sep 30, 2024 24.95%
Sep 30, 2024 24.95%
Jun 30, 2024 36.02%
Jun 30, 2024 36.02%
Mar 31, 2024 21.82%
Mar 31, 2024 21.82%
Dec 31, 2023 32.01%
Dec 31, 2023 32.01%